Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 17 of 21, showing 5 Applications out of 104 total, starting on record 81, ending on 85

# Protocol No Study Title Investigator(s) & Site(s)

81.

ECCT/14/12/01   Rivaroxaban for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE)
    XALIA LEA- Xarelto® for Long-term and  Initial Anticoagulation in Venous  Thromboembolism (VTE) in Latin America,  EMEA and Asia   
Principal Investigator(s)
1. Anne Njeri Mugera Njambi Mugera
2. Dr. Martin N Wanyoike Njoroge Wanyoike
3. Charles Muthui Kariuki Muthui Kariuki
4. FEROZ ALI Allibhoy
Site(s) in Kenya
1. Primecare Heart Clinic (Nairobi City county)
2. Dr. Silversteins Clinic (Nairobi City county)
3. Nairobi Cardiovascular Clinic (Nairobi City county)
4. Agah Khan Kisumu (Kisumu county)
 
View

82.

ECCT/14/07/01  
    POST STABILIZATION VERSUS URGENT START OF HAART IN HIV-1 INFECTED CHILDREN WITH SEVERE COINFECTION   
Principal Investigator(s)
1. Grace John-Stewart
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Odinga Teaching and Referral Hospital (Kisumu county)
3. Kisumu East District Hospital (Kisumu county)
 
View

83.

ECCT/14/05/03   Invivo II study
    Therapeutic efficacy of dihydroartemisinin piperaquine and artemether lumefantrine for the treatment of uncomplicated malaria  in Kisumu County, Western Kenya   Therapeutic efficacy of dihydroartemisinin piperaquine and artemether lumefantrine for the treatment of uncomplicated malaria  in Kisumu County, Western Kenya   
Principal Investigator(s)
1. Ben Andagalu
Site(s) in Kenya
Kombewa Clinical Research Center
 
View

84.

ECCT/14/05/02   Invivo I study
    In vivo and in vitro efficacy of artemisinin combination therapy in Kisumu County, Western Kenya.   
Principal Investigator(s)
1. Ben Andagalu
Site(s) in Kenya
Kombewa Clinical Research Center
 
View

85.

ECCT/14/03/02   Rivaroxaban on prevention of stroke and non-central nervous system systemic embolism in patients with non valvular atrial fibrillation
    XANTUS-EL, Xarelto on prevention of stroke and non-central nervous system systemic embolism in patients with non valvular atrial fibrillation - a non interventional study, XA 1206 (IMPACT No. 16691)       
Principal Investigator(s)
1. Warshow Majid Mbarak
Site(s) in Kenya
1. MP Shah Hospital (Nairobi City county)
 
View